Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women.

Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women.
复制标题

DOI:
10.1089/thy.1998.8.1081
复制
发表时间:
1998-12
期刊:
Thyroid : official journal of the American Thyroid Association
影响因子:
--
通讯作者:
M. Diekman;J. Romijn;E. Endert;H. Sauerwein;W. Wiersinga
M. Diekman;J. Romijn;E. Endert;H. Sauerwein;W. Wiersinga
中科院分区:
其他
文献类型:
--
作者:
M. Diekman;J. Romijn;E. Endert;H. Sauerwein;W. Wiersinga

文献摘要

被引文献

相似文献

甲状腺激素和瘦素都参与能量代谢的调节。血清瘦素浓度测定甲状腺毒症(n = 21,平均年龄45岁)或甲状腺功能减退症(n = 14,平均年龄44岁)的妇女甲状腺功能正常状态恢复前和3个月后。治疗后甲状腺功能减退(14.7+/-3.5 vs 17.8+/-3.9 ng/ml,p = 0.06)和甲状腺功能亢进(11.9+/-1.7 vs 14.4+/-2.0,p = 0.08)的妇女血清瘦素浓度有增加的趋势(未治疗和甲状腺功能正常状态下的值分别为平均值+/- SE)。甲状腺功能亢进妇女的体重指数(BMI)低于未治疗状态下甲状腺功能减退妇女(22.1+/-0.7 vs. 26.2+/-1.9,p < 0.05)。治疗后两组的BMI没有差异(24.5+/-0.7 vs. 26.3+/-2.1,p = 0.37),因为甲状腺功能亢进女性的BMI增加;甲状腺功能减退组的BMI没有变化。在多变量回归分析中,控制BMI后,甲状腺功能减退妇女的血清瘦素浓度低于甲状腺功能亢进妇女(p < 0.05),而治疗后瘦素值无差异(p = 0.44)。当瘦素浓度用与先前报道的BMI和年龄相匹配的女性对照组的平均值的标准差分数(Z分数)表示时,甲状腺功能减退的女性的Z分数低于甲状腺功能亢进的女性(-0.63+/-0.21 vs. 0.53+/-0.18,p = 0.001)。治疗后,Z评分未偏离预期值(0.05+/-0.28 vs. 0.08+/-0.16,p = 0.98)。甲状腺功能减退(p = 0.01)和甲状腺功能亢进(p = 0.02)患者治疗前后的Z评分不同。总之,这些数据在甲状腺功能亢进和甲状腺功能减退的妇女表明,甲状腺状态调节血清瘦素浓度独立的BMI,甲状腺功能减退症和甲状腺毒症的一个小的减少和一个小的增加。
Thyroid hormones and leptin are both involved in the regulation of energy metabolism. Serum leptin concentrations were measured in women with thyrotoxicosis (n = 21, mean age 45 years) or hypothyroidism (n = 14, mean age 44 years) before and 3 months after restoration of the euthyroid state. Serum leptin concentration tended to increase in both hypothyroid (14.7+/-3.5 vs 17.8+/-3.9 ng/ml, p = 0.06) and thyrotoxic (11.9+/-1.7 vs 14.4+/-2.0, p = 0.08) women after treatment (values given as mean +/- SE in the untreated and the euthyroid state respectively). Body mass index (BMI) was lower in thyrotoxic women than in hypothyroid women in the untreated state (22.1+/-0.7 vs. 26.2+/-1.9, p < 0.05). BMI was not different between both groups after treatment (24.5+/-0.7 vs. 26.3+/-2.1, p = 0.37), due to an increase of BMI in the thyrotoxic women; BMI did not change in the hypothyroid group. After controlling for BMI in a multivariate regression analysis, serum leptin concentrations were lower in hypothyroid women than in thyrotoxic women (p < 0.05), whereas posttreatment values of leptin did not differ (p = 0.44). When leptin concentrations were expressed as standard deviation scores (Z-scores) from the mean value of female controls matched for BMI and age as reported earlier, Z-scores were lower in the hypothyroid than in the thyrotoxic women (-0.63+/-0.21 vs. 0.53+/-0.18, p = 0.001). After treatment, Z-scores did not deviate from the expected values (0.05+/-0.28 vs. 0.08+/-0.16, p = 0.98). Z-scores differed before and after treatment in both hypothyroid (p = 0.01) and thyrotoxic (p = 0.02) patients. In conclusion, these data obtained in thyrotoxic and hypothyroid women indicate that thyroid states modulates serum leptin concentrations independent of BMI, with a small decrease in hypothyroidism and a small increase in thyrotoxicosis.